Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere LH Wong, KH Brettingham-Moore, L Chan, JM Quach, MA Anderson, ... Genome research 17 (8), 1146-1160, 2007 | 339 | 2007 |
Correction: LINE Retrotransposon RNA Is an Essential Structural and Functional Epigenetic Component of a Core Neocentromeric Chromatin AC Chueh, EL Northrop, KH Brettingham-Moore, KHA Choo, LH Wong PLoS genetics 5 (2), 2009 | 188 | 2009 |
LINE retrotransposon RNA is an essential structural and functional epigenetic component of a core neocentromeric chromatin AC Chueh, EL Northrop, KH Brettingham-Moore, KHA Choo, LH Wong PLoS genetics 5 (1), e1000354, 2009 | 188 | 2009 |
RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization A Young, R Berry, AF Holloway, NB Blackburn, JL Dickinson, M Skala, ... BMC cancer 14 (1), 808, 2014 | 72 | 2014 |
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma. KH Brettingham-Moore, CP Duong, DM Greenawalt, AG Heriot, J Ellul, ... Clinical cancer research, clincanres. 2915.2010, 2011 | 67 | 2011 |
GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements KH Brettingham-Moore, S Rao, T Juelich, MF Shannon, AF Holloway Nucleic acids research 33 (1), 225-234, 2005 | 49 | 2005 |
Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia KH Brettingham-Moore, PC Taberlay, AF Holloway Frontiers in immunology 6, 499, 2015 | 36 | 2015 |
Using gene expression profiling to predict response and prognosis in gastrointestinal cancers—the promise and the perils KH Brettingham-Moore, CP Duong, AG Heriot, RJS Thomas, WA Phillips Annals of surgical oncology 18 (5), 1484-1491, 2011 | 36 | 2011 |
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil AL Patchett, R Latham, KH Brettingham-Moore, C Tovar, AB Lyons, ... Developmental & Comparative Immunology 53 (1), 123-133, 2015 | 26 | 2015 |
Determinants of a transcriptionally competent environment at the GM-CSF promoter KH Brettingham-Moore, OR Sprod, X Chen, P Oakford, MF Shannon, ... Nucleic acids research 36 (8), 2639-2653, 2008 | 22 | 2008 |
DNA methylation changes following DNA damage in prostate cancer cells LP Sutton, SA Jeffreys, JL Phillips, PC Taberlay, AF Holloway, M Ambrose, ... Epigenetics, 1-14, 2019 | 21 | 2019 |
Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells JL Phillips, PC Taberlay, AM Woodworth, K Hardy, ... Journal of cellular physiology 233 (4), 3439-3453, 2018 | 15 | 2018 |
Molecular changes in the phosphatidylinositide 3‐kinase (PI3K) pathway are common in gastric cancer TN Tran, K Brettingham‐Moore, CP Duong, C Mitchell, NJ Clemons, ... Journal of surgical oncology 108 (2), 113-120, 2013 | 15 | 2013 |
mRNA gene expression correlates with histologically diagnosed chemotherapy‐induced hepatic injury CHC Pilgrim, K Brettingham‐Moore, A Pham, W Murray, E Link, M Smith, ... HPB 13 (11), 811-816, 2011 | 13 | 2011 |
Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation FS Poke, WR Upcher, OR Sprod, A Young, KH Brettingham-Moore, ... PloS one 7 (7), e41734, 2012 | 10 | 2012 |
The leukemia inhibitory factor receptor gene is a direct target of RUNX1 AA Qadi, PC Taberlay, JL Phillips, A Young, AC West, ... Journal of cellular biochemistry 117 (1), 49-58, 2016 | 9 | 2016 |
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target SM Navickas, KA Giles, KH Brettingham-Moore, PC Taberlay Oncogene, 1-11, 2023 | 7 | 2023 |
Cancer Epigenetics KH Brettingham-Moore, PC Taberlay Drug Discovery in Cancer Epigenetics, 41-59, 2016 | 6 | 2016 |
Cancer Epigenetics K Brettingham-Moore, P Taberlay University Of Tasmania, 2015 | 1 | 2015 |
Chromatin Remodelling: Distinct molecular events during differentiation and activation of T cells FM Shannon, X Chen, K Brettingham-Moore, A Holloway Current Immunology Reviews 2 (3), 273-289, 2006 | 1 | 2006 |